Guo Q, Gao B, Song R, Li W, et al. FZ-AD005, a Novel DLL3-Targeted Antibody-Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models. Mol Cancer Ther 2024;23:1367-1377.
PMID: 38940283